Lead: Review of Evidence on Alcohol and Health
Review of Evidence on Alcohol and Health National Academies of Sciences, Engineering, and Medicine To inform the next edition of the Dietary Guidelines for Americans (DGA), Congress tasked the Nationa...
14 Tammi 20256min
Lead: The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies Psychological Medicine Using data from the EU-GEI ca...
17 Joulu 20247min
Lead: Prevalence of pharmacotherapy for attention-deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students
Prevalence of pharmacotherapy for attention-deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students Addiction This is an observational study using cro...
10 Joulu 20247min
Lead: Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine
Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine Clinical Chemistry This study of xylazine pharmacokinetics used plasma samples from 28 patients who had urine screens ...
4 Joulu 20245min
Lead: Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study
Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study 🔓 Addiction This retrospective cohort study aimed to determine if opi...
19 Marras 20247min
Lead: Links between adolescent binge drinking and midlife alcohol use behaviors by age, sex, and race/ethnicity
Links between adolescent binge drinking and midlife alcohol use behaviors by age, sex, and race/ethnicity 🔓 Alcohol Clinical and Experimental Research Using data from the Monitoring the Future study,...
5 Marras 20247min
Lead: Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder
Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder JAMA Network This population-based retrospective cohort study assessed whether the use of buprenorphine/naloxone is associa...
29 Loka 20245min
Lead: Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization
Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization 🔓 JAMA Network Open This cross-sectional study using health care claims data from 35,451 US adults with an opioid use ...
22 Loka 20245min
